Crohn's disease: innate immunodeficiency?

PubWeight™: 0.84‹?›

🔗 View Article (PMC 4087427)

Published in World J Gastroenterol on November 14, 2006

Authors

Jesus-K Yamamoto-Furusho1, Joshua-R Korzenik

Author Affiliations

1: Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114, USA. kazuofurusho@hotmail.com

Associated clinical trials:

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease (ADcSVF-IBD) | NCT02952131

Articles cited by this

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science (2005) 11.31

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem (2003) 10.79

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem (2003) 9.37

Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity (1999) 7.90

Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem (2000) 6.54

Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet (2006) 5.83

NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol (2004) 5.59

Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science (2005) 5.25

Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol (2006) 4.55

NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut (2004) 4.39

The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology (2002) 4.20

Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem (2003) 3.83

CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology (2003) 3.70

The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr Biol (2004) 3.54

Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet (2005) 2.93

Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet (2002) 2.74

Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut (2003) 2.74

Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol (2005) 2.52

Neutrophil dysfunction in Crohn's disease. Lancet (1976) 2.47

Sargramostim for active Crohn's disease. N Engl J Med (2005) 2.24

Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet (2004) 2.23

Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci U S A (1997) 2.14

Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition. J Cell Biol (2005) 2.03

NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur J Immunol (2004) 1.90

Crohn's disease: a defensin deficiency syndrome? Eur J Gastroenterol Hepatol (2003) 1.72

Inflammatory bowel disease in glycogen storage disease type Ib. J Pediatr (1986) 1.57

Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood (1998) 1.35

Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation. J Leukoc Biol (2006) 1.22

Colitis in chronic granulomatous disease. Gastroenterology (1982) 1.21

Identification of GM-CSF in Paneth cells using single-cell RT-PCR. Biochem Biophys Res Commun (2003) 1.11

An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease. Aliment Pharmacol Ther (2005) 1.11

Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig Dis Sci (2000) 1.05

Leucocyte adhesion deficiency presenting as a chronic ileocolitis. Gut (1996) 0.99

Turner's syndrome associated with chronic inflammatory bowel disease. A case report and review of the literature. Acta Med Scand (1988) 0.92

Colony-stimulating factor-1 promotes clonogenic growth of normal murine colonic crypt epithelial cells in vitro. J Interferon Cytokine Res (2004) 0.92

Redox state and O2*- production in neutrophils of Crohn's disease patients. Exp Biol Med (Maywood) (2006) 0.90

Superoxide production by Crohn's disease neutrophils. Gut (1991) 0.90

Granulomatous enterocolitis associated with Hermansky-Pudlak syndrome. Am J Gastroenterol (2006) 0.89

Function of exudative neutrophilic granulocytes in patients with Crohn's disease or ulcerative colitis. Scand J Gastroenterol (1985) 0.89

Chronic inflammatory bowel disease in glycogen storage disease type 1B. J Inherit Metab Dis (1991) 0.88

Chediak-Higashi syndrome with intestinal complication. Report of a case. J Clin Gastroenterol (1987) 0.83

Crohn's disease associated with autoimmune neutropenia. J Clin Gastroenterol (1991) 0.80

Crohn's disease associated with cyclic neutropenia. Am J Gastroenterol (1992) 0.80

Complement and function of neutrophils in chronic inflammatory bowel disease. Dan Med Bull (1986) 0.79

[Chronic neutropenia and Crohn's disease in childhood. Report of 2 cases ]. Arch Fr Pediatr (1982) 0.79

Articles by these authors

Innate immunity in inflammatory bowel disease. World J Gastroenterol (2007) 1.13